Abilify Can Worsen Psychosis and Aggression
June 8, 2013
In a systematic literature review, researchers from Canada and Japan found that the antipsychotic aripiprazole (Abilify) was significantly and causally related to increased increased psychosis, agitation and aggression. Results appear in this month’s Psychopharmacology.
Takeuchi, H., Remington, G.; A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder. Psychopharmacology. Online June 2013
This entry was posted in Adult, Antipsychotics, Disorders, Featured News, In the News, Psychiatric Drugs, Schizophrenia/Psychotic Disorders by Kermit Cole. Bookmark the permalink.
Related Posts:
Thank You Mad In America
Toss yet another report on the pile, and no matter how Many of these reports surface, 'Researchers' must continue to 'Research'.
As we never tire of pointing out:
"Hope remains for a cure, because Research (into how to keep defrauding the public, insurers, and patients Out of Their money, Health, Lives, and Civil Rights) Must Continue."
In case you missed it, What this FDA approved Aggression, Violence, and Psychosis inducing poison actually IS: (according to the FDA's own Medwatch)
Abilify
No comments:
Post a Comment